Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO umbilical vessel catheters; DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; FINESSE+ generators; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, it provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS endoscopic irrigation devices; suprapubic catheterization; LIBERTY urinary incontinence treatment and control systems; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN tool to manipulate the uterus in laparoscopic procedures. Additionally, the company offers DELTRAN, a disposable pressure transducer; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health centers in hospitals, outpatient clinics, and physician's offices through direct customer service and sales force, independent consultants, and manufacturer representatives. The company was incorporated in 1978 and is headquartered in Midvale, Utah.
Utah Medical Products Dividend Announcement
• Utah Medical Products announced a quarterly dividend of $0.30 per ordinary share which will be made payable on 2025-01-03. Ex dividend date: 2024-12-16
• Utah Medical Products annual dividend for 2024 was $1.21
• Utah Medical Products annual dividend for 2023 was $1.18
• Utah Medical Products's trailing twelve-month (TTM) dividend yield is 1.82%
• Utah Medical Products's payout ratio for the trailing twelve months (TTM) is 28.13%
• Utah Medical Products's dividend growth over the last five years (2018-2023) was 1.78% year
• Utah Medical Products's dividend growth over the last ten years (2013-2023) was 1.87% year
Utah Medical Products Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-12-16 | $0.30 | quarterly | 2025-01-03 |
2024-09-20 | $0.30 | quarterly | 2024-10-04 |
2024-06-14 | $0.30 | quarterly | 2024-07-05 |
2024-03-14 | $0.30 | quarterly | 2024-04-03 |
2023-12-14 | $0.30 | quarterly | 2024-01-03 |
2023-09-14 | $0.29 | quarterly | 2023-10-03 |
2023-06-15 | $0.29 | quarterly | 2023-07-06 |
2023-03-16 | $0.29 | quarterly | 2023-04-04 |
2022-12-15 | $0.29 | quarterly | 2023-01-04 |
2022-09-15 | $0.29 | quarterly | 2022-10-05 |
2022-06-16 | $0.29 | quarterly | 2022-07-06 |
2022-03-17 | $0.29 | quarterly | 2022-04-05 |
2021-12-14 | $2.00 | quarterly | 2021-12-29 |
2021-09-15 | $0.28 | quarterly | 2021-10-05 |
2021-06-14 | $0.28 | quarterly | 2021-07-06 |
2021-03-16 | $0.28 | quarterly | 2021-04-02 |
2020-12-14 | $0.28 | quarterly | 2021-01-05 |
2020-09-14 | $0.28 | quarterly | 2020-10-05 |
2020-06-16 | $0.28 | quarterly | 2020-07-03 |
2020-03-12 | $0.28 | quarterly | 2020-04-02 |
2019-12-12 | $0.28 | quarterly | 2020-01-03 |
2019-09-12 | $0.28 | quarterly | 2019-10-03 |
2019-06-13 | $0.28 | quarterly | 2019-07-03 |
2019-03-14 | $0.28 | quarterly | 2019-04-02 |
2018-12-13 | $0.28 | quarterly | 2019-01-03 |
2018-09-13 | $0.27 | quarterly | 2018-10-02 |
2018-06-14 | $0.27 | quarterly | 2018-07-06 |
2018-03-15 | $0.27 | quarterly | 2018-04-03 |
2017-12-14 | $0.27 | quarterly | 2018-01-03 |
2017-09-14 | $0.27 | quarterly | 2017-10-03 |
2017-06-14 | $0.27 | quarterly | 2017-07-06 |
2017-03-15 | $0.27 | quarterly | 2017-04-04 |
2016-12-14 | $0.27 | quarterly | 2016-12-30 |
2016-09-14 | $0.26 | quarterly | 2016-10-04 |
2016-06-15 | $0.26 | quarterly | 2016-07-06 |
2016-03-16 | $0.26 | quarterly | 2016-04-06 |
2015-12-14 | $0.26 | quarterly | 2015-12-30 |
2015-09-16 | $0.26 | quarterly | 2015-10-02 |
2015-06-17 | $0.26 | quarterly | 2015-07-02 |
2015-03-16 | $0.26 | quarterly | 2015-04-02 |
2014-12-12 | $0.26 | quarterly | 2014-12-30 |
2014-09-16 | $0.25 | quarterly | 2014-10-02 |
2014-06-16 | $0.25 | quarterly | 2014-07-03 |
2014-03-14 | $0.25 | quarterly | 2014-04-02 |
2013-12-12 | $0.25 | quarterly | 2013-12-30 |
2013-09-12 | $0.24 | quarterly | 2013-10-04 |
2013-06-12 | $0.24 | quarterly | 2013-07-03 |
2013-03-15 | $0.24 | quarterly | 2013-04-04 |
Utah Medical Products Dividend per year
Utah Medical Products Dividend growth
Utah Medical Products Dividend Yield
Utah Medical Products current trailing twelve-month (TTM) dividend yield is 1.82%. Interested in purchasing Utah Medical Products stock? Use our calculator to estimate your expected dividend yield:
Utah Medical Products Financial Ratios
Utah Medical Products Dividend FAQ
Other factors to consider when evaluating Utah Medical Products as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Utah Medical Products stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Utah Medical Products's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Utah Medical Products publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Utah Medical Products distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Utah Medical Products are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Utah Medical Products sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Utah Medical Products distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Utah Medical Products declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Utah Medical Products's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Utah Medical Products's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.